- Home
- IBCP vs FDMT Comparison
IBCP vs FDMT Comparison
Compare IBCP & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IBCP | FDMT |
|---|---|---|
| Founded | 1864 | 2013 |
| Country | United States | United States |
| Employees | 270 | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 776.0M | 695.3M |
| IPO Year | 2010 | 2019 |
Fundamental Metrics
Financial Performance| Metric | IBCP | FDMT |
|---|---|---|
| Price | $38.40 | $11.52 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | ★ $37.00 | $31.71 |
| AVG Volume (30 Days) | 193.2K | ★ 577.3K |
| Earning Date | 04-23-2026 | 05-08-2026 |
| Dividend Yield | ★ 3.35% | N/A |
| EPS Growth | 3.48 | ★ 18.79 |
| EPS | ★ 1.72 | N/A |
| Revenue | $32,075,000.00 | ★ $85,209,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $8.98 | $70.28 |
| P/E Ratio | $22.26 | ★ N/A |
| Revenue Growth | 0.30 | ★ 230194.60 |
| 52 Week Low | $29.83 | $5.97 |
| 52 Week High | $39.24 | $14.00 |
Technical Indicators
Market Signals| Indicator | IBCP | FDMT |
|---|---|---|
| Relative Strength Index (RSI) | 61.76 | 58.16 |
| Support Level | $35.16 | $9.63 |
| Resistance Level | $39.24 | $11.89 |
| Average True Range (ATR) | 0.60 | 0.60 |
| MACD | -0.07 | 0.17 |
| Stochastic Oscillator | 53.13 | 81.58 |
Price Performance
Historical ComparisonAbout IBCP Independent Bank Corporation
Independent Bank Corp. operates as a commercial bank. It offers a broad range of banking services to individuals and businesses, including checking and savings accounts, commercial lending, direct and indirect consumer financing, mortgage lending, and safe deposit box services. It also provides internet and mobile banking capabilities to its customers. The firm's principal markets are the rural and suburban communities across Lower Michigan. The firm generates the majority of its revenue from Interest and fees on loans.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).